-
Sony and Illumina Set to Change the Way Doctors Identify and Treat Cancer (ILMN, SNE)
Thursday, September 5, 2013 - 2:55pm | 519In a story first reported by Nikkei and updated recently by Le Monde, Sony Corp. (NYSE: SNE) and U.S. genome sequencing equipment maker Illumina Inc. (NASDAQ: ILMN) plan to launch a human genome analysis project in October. The project will involve the study and analysis of genetic material...